GE HealthCare Launches a New AI Suite for Early Breast Cancer Detection
References: gehealthcare & medcitynews
GE Healthcare has unveiled the MyBreastAI suite, an AI-powered solution presented at RSNA 2023, the annual radiology conference in Chicago. This innovative product aims to streamline radiologists' workflows, particularly in the challenging task of reading hundreds of breast images daily.
Developed in collaboration with iCAD, MyBreastAI integrates three AI applications. The ProFound AI for DBT assists radiologists in diagnostic decision-making by providing insights on case scores and the certainty level in identifying malignant tissue densities. SecondLook for 2D Mammography also flags regions of interest on mammograms, alerting radiologists after their initial reading. The suite's third AI solution, PowerLook Density Assessment, standardizes breast density assessment and reporting, reducing variability among radiologists.
The MyBreastAI suite is set to be initially available for purchase by U.S. healthcare providers.
Image Credit: GE Healthcare
Developed in collaboration with iCAD, MyBreastAI integrates three AI applications. The ProFound AI for DBT assists radiologists in diagnostic decision-making by providing insights on case scores and the certainty level in identifying malignant tissue densities. SecondLook for 2D Mammography also flags regions of interest on mammograms, alerting radiologists after their initial reading. The suite's third AI solution, PowerLook Density Assessment, standardizes breast density assessment and reporting, reducing variability among radiologists.
The MyBreastAI suite is set to be initially available for purchase by U.S. healthcare providers.
Image Credit: GE Healthcare
Trend Themes
1. AI-powered Workflow Streamlining - The MyBreastAI suite aims to streamline radiologists' workflows, particularly in the challenging task of reading hundreds of breast images daily.
2. Diagnostic Decision-making Support - The ProFound AI for DBT assists radiologists in diagnostic decision-making by providing insights on case scores and the certainty level in identifying malignant tissue densities.
3. Standardizing Breast Density Assessment - PowerLook Density Assessment standardizes breast density assessment and reporting, reducing variability among radiologists.
Industry Implications
1. Healthcare Technology - The MyBreastAI suite presents disruptive innovation opportunities in the healthcare technology industry, particularly in streamlining radiologists' workflows and providing diagnostic decision-making support.
2. Artificial Intelligence - The AI-powered solutions offered by the MyBreastAI suite present disruptive innovation opportunities in the artificial intelligence industry, particularly in the field of medical image analysis and diagnostic decision-making.
3. Radiology - The MyBreastAI suite introduces disruptive innovation opportunities in the radiology industry, particularly in standardizing breast density assessment and improving the accuracy of breast cancer detection.
5.1
Score
Popularity
Activity
Freshness
